Drawing for CALMEX

USPTO serial 97337833

CALMEX

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
HISER, CHARLES
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CALMEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen Driscoll

STEPHEN DRISCOLL FISHERBROYLES LLP1650 MARKET STREETPHILADELPHIA, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Topical analgesic creamsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2023MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jun 26, 2023ABN5ABANDONMENT - AFTER PUBLICATION—
Jun 19, 2023EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Mar 13, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2023DOCKASSIGNED TO EXAMINER—
Apr 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance